TNGX: Tango Therapeutics, Inc. insider trading, 5% holders and institutional ownership

From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.

Insider trading

0 open-market buys totaling - and 5 sales totaling $859K in the last 180 days.

Insider sales

Trade dateInsiderRoleValue10b5-1 plan
2026-10-01Crystal AdamPresident$646Kyes
2026-10-01Crystal AdamPresident$15Kyes
2026-09-22Newcomb JessicaOfficer$16Kyes
2026-09-22Newcomb JessicaOfficer$122Kyes
2026-09-22Newcomb JessicaOfficer$60Kyes

Activist and 5% holders

FiledWhatHolderStakeChangeFiling
2026-08-14Fell below 5%Nextech Crossover I GP S.a. r.l.0.00%SEC
2026-08-1413G amendmentTCG Crossover GP II, LLC7.00%SEC
2026-08-14New 13G stakeTHE GOLDMAN SACHS GROUP, INC.6.00%SEC
2026-08-14Fell below 5%Woodline Partners LP2.50%SEC
2026-08-1413G amendmentFarallon Capital Management, L.L.C.9.80%SEC
2026-08-12Fell below 5%Adage Capital Management, L.P.3.44%SEC

Get new insider and activist filings the morning after: daily alerts. Not investment advice.